Research programme: calcineurin inhibitors - Biotica TechnologyAlternative Names: nPT-CLN
Latest Information Update: 16 Jul 2016
At a glance
- Originator Biotica Technology
- Class Lactones; Macrolides
- Mechanism of Action Calcineurin inhibitors; Cytokine inhibitors; Immunosuppressants; T cell activation inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- Available For Licensing Yes - Asthma
Highest Development Phases
- No development reported Asthma
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Asthma in United Kingdom (Inhalation)
- 02 Oct 2009 Preclinical trials in Asthma in United Kingdom (Inhalation)